Wilson & Boucher Capital Management LLC Has $437,000 Stock Position in McKesson Co. (NYSE:MCK)

Wilson & Boucher Capital Management LLC reduced its holdings in shares of McKesson Co. (NYSE:MCK) by 12.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 768 shares of the company’s stock after selling 114 shares during the period. Wilson & Boucher Capital Management LLC’s holdings in McKesson were worth $437,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Millstone Evans Group LLC acquired a new position in shares of McKesson during the fourth quarter worth $28,000. Synergy Asset Management LLC bought a new stake in McKesson during the 4th quarter worth $32,000. Crews Bank & Trust acquired a new position in McKesson in the 4th quarter worth about $33,000. Atala Financial Inc bought a new position in McKesson in the fourth quarter valued at about $34,000. Finally, Graney & King LLC acquired a new stake in shares of McKesson during the fourth quarter valued at about $38,000. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Trading Up 0.7%

Shares of MCK opened at $715.44 on Friday. The firm’s fifty day simple moving average is $689.88 and its two-hundred day simple moving average is $633.70. McKesson Co. has a 12 month low of $464.42 and a 12 month high of $731.00. The stock has a market capitalization of $89.51 billion, a P/E ratio of 32.76, a price-to-earnings-growth ratio of 1.29 and a beta of 0.53.

McKesson (NYSE:MCK) last released its earnings results on Thursday, May 8th. The company reported $10.12 EPS for the quarter, topping the consensus estimate of $9.83 by $0.29. The business had revenue of $90.82 billion during the quarter, compared to analysts’ expectations of $94 billion. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The firm’s revenue was up 18.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.18 earnings per share. As a group, research analysts predict that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.40%. The ex-dividend date is Monday, June 2nd. McKesson’s dividend payout ratio is presently 10.99%.

Insiders Place Their Bets

In related news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the stock in a transaction on Monday, May 19th. The stock was sold at an average price of $726.51, for a total value of $394,494.93. Following the transaction, the chief accounting officer now directly owns 1,972 shares in the company, valued at $1,432,677.72. This trade represents a 21.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Britt J. Vitalone sold 6,336 shares of McKesson stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $717.30, for a total transaction of $4,544,812.80. Following the completion of the sale, the chief financial officer now directly owns 14,760 shares of the company’s stock, valued at approximately $10,587,348. The trade was a 30.03% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,127 shares of company stock worth $5,834,498. 0.11% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on MCK. UBS Group upped their price objective on McKesson from $708.00 to $805.00 and gave the company a “buy” rating in a research note on Tuesday, April 29th. Wall Street Zen lowered shares of McKesson from a “strong-buy” rating to a “buy” rating in a report on Wednesday. Morgan Stanley raised their price target on shares of McKesson from $642.00 to $745.00 and gave the company an “overweight” rating in a research note on Wednesday, April 2nd. Bank of America lifted their price target on shares of McKesson from $755.00 to $800.00 and gave the stock a “buy” rating in a report on Friday, May 9th. Finally, Mizuho boosted their price objective on shares of McKesson from $630.00 to $690.00 and gave the stock a “neutral” rating in a research note on Thursday, April 3rd. Three analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $686.69.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.